Cite

HARVARD Citation

    Chi, P. et al. (2022). Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor. Journal of clinical oncology. 40 (9), pp. 997-1008. [Online]. 
  
Back to record